3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
46
Phase EARLY_PHASE1
5
Phase 2
5
Phase 4
2
Phase 1/2
2
Phase 1
2
Phase 3
1
Status
Recruiting
1
Not yet recruiting
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
3
Dermatologic
3
Thoracic
2
Breast
2
Other hematologic neoplasm
1
Conditions
Breast Neoplasms
2
Interventions
Letrozole
23
Docetaxel
17
Cyclophosphamide
13
Zoledronic Acid
12
Trastuzumab
12
Anastrozole
12
exemestane
11
Tamoxifen
11
Paclitaxel
11
Capecitabine
10
Fulvestrant
8
Epirubicin
8
pegfilgrastim
7
Saline Solution
7
Bupivacaine
7
pertuzumab
6
liposomal doxorubicin
6
abemaciclib
6
Sodium Chloride
6
Filgrastim
6
Carboplatin
6
pegylated granulocyte colony-stimulating factor
5
palbociclib
5
Ropivacaine
5
Dexmedetomidine
5
Bevacizumab
5
ribociclib
4
eribulin
4
Vinorelbine
4
Tranexamic Acid
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 4
×
Blood Specimen Collection
×
Breast
×
Clear all
NCT06274515
2026-06-04
REMERGE
Hoffmann-La Roche
Phase 4
Recruiting
320 enrolled
NCT07490509
2026-04-01
DOSABEMA
Poitiers University Hospital
Phase 4
Not yet recruiting
235 enrolled